Clindamycin Hydrochloride
Product Images NDC 60760-484

2 FDA label images from St. Mary's Medical Park Pharmacy · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clindamycin Hydrochloride (NDC 60760-484). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clinda (Clindamycin 60760 484 20)

Clinda (Clindamycin 60760 484 20)
Packaging label for Clindamycin Hydrochloride Capsules, USP 300 mg, with a quantity of 20 capsules. The label includes the NDC number 60760-484-20 and states it is packaged by St. Mary's Medical Park Pharmacy in Oro Valley, AZ. The product is manufactured by Sun Pharmaceutical Industries Limited, Gujarat, India. Instructions indicate 'Use as directed' and storage at controlled room temperature (15°-30°C).*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of clindamycin hydrochloride showing its molecular configuration including the substituted pyrrolidine ring and sugar moiety with hydrochloride indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.